Navigation Links
Morphine may excite cancerous tumors

According to a new study, morphine may be combined with tumor growth in mice. At present there is no scientific data that indicates morphine or similar pain medications will lead to increased cancer growth in humans.// However, researchers say their findings warrant further studies for managing cancer pain.

Researchers from the University of Minnesota Cancer Center found doses of morphine, similar to doses given to cancer patients to manage severe pain, provoke signals in endothelial cells, or cells that form blood vessels, and activate mitogen-activated protein kinase (MAPK). MAPK promotes endothelial cell multiplication and angiogenesis, or formation of new blood vessels. Angiogenesis can cause tumor growth by providing nutrients to growing tumors and by transporting cancer cells from a tumor to other parts of the body.

Lead researcher Kalpna Gupta, Ph.D., from the University of Minnesota felt that, despite the widespread use of morphine to treat pain in many medical conditions like cancer, little was known about how this drug affects blood vessels or cancer. Our study shows that morphine stimulates the formation of new blood vessels inside the tumor, which in turn allows increased growth of tumors in mice. Hence Authors of the study note that morphine did not promote initial or early growth of tumors in this study.


'"/>




Page: 1

Related medicine news :

1. Morphine Withdrawal Complicates Hepatitis C Infection in Drug Abusers
2. Using Morphine to Hasten Death Is a Myth, Says Doctor
3. How Morphine Affects Memory
4. Gene causes moles to become cancerous
5. Moles become cancerous due to genes
6. Benign eye tumors being treated
7. Resistant tumors could be treated with the discovery of a new molecule within cancer cells
8. Finasteride lowers risk of prostate cancer but increases risk of high-grade tumors
9. Finasteride lowers risk of prostate cancer but increases risk of high-grade tumors
10. Same molecule found in meat, milk, tumors
11. Women with borderline ovarian tumors can still preserve their fertility
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/29/2016)... Texas (PRWEB) , ... April 29, 2016 , ... Spine ... neck pain, is proud to announce one of their physicians has been invited to ... Family Physicians (Texas ACOFP) Family Practice Review conference on April 30, 2016. , ...
(Date:4/29/2016)... ... 29, 2016 , ... The Gluten-Free Certification Program (GFCP), in ... the launch of the GFCP Scoop in response to consumer demand ... the GFCP Scoop site is to keep the gluten-free community updated ...
(Date:4/29/2016)... ... ... Reltok Nasal Products proudly announces that Boston Medical Products, Inc., a leading ... specialty, has added the KOTLER NASAL AIRWAY™ to its diverse product line. , A ... safety device secured by nasal surgeons onto the floor of the nasal passages, at ...
(Date:4/29/2016)... ... April 29, 2016 , ... Regenerative Medicine Solutions ... Work employee satisfaction survey, earning them second place for Tampa’s Best Places to Work. ... , “This is a great accomplishment for our team,” says RMS Human Resources ...
(Date:4/29/2016)... ... April 29, 2016 , ... Natren, Inc. recently ... of probiotics, Petbiotics ™, as they fondly call them. As animal lovers, ... networking for their non-profit organizations. Animal rescues across the nation face huge hurdles ...
Breaking Medicine News(10 mins):
(Date:4/28/2016)... Calif. , April 28, 2016  Marking ... widely accessible breast and ovarian cancer risk test, ... panel analyzing 30 genes that highly impact the ... women. Available today, the Color Test analyzes hereditary ... prostate, stomach, and uterine cancers. The Color Test ...
(Date:4/28/2016)... April 28, 2016  The blood testing market in ... according to Kalorama Information and The Freedonia Group in ... nucleic acid testing.  The healthcare research firm said that ... developing blood collection stations and in improving testing at ... Information,s report, Blood Testing Market in China ...
(Date:4/28/2016)... , Net Sales of $1.90 billion represent an increase ... period, and an increase of 1.2% on an adjusted pro ... first quarter were $0.52 reported, a decrease of 47.5% from ... 29.9% over the prior year period , The Company ... Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) ...
Breaking Medicine Technology: